SI0625351T1 - Use of Etofibrate and pharmaceutical compositions containing etofibrate in the treatment of diabetic angio- and retinopathy - Google Patents

Use of Etofibrate and pharmaceutical compositions containing etofibrate in the treatment of diabetic angio- and retinopathy

Info

Publication number
SI0625351T1
SI0625351T1 SI9430223T SI9430223T SI0625351T1 SI 0625351 T1 SI0625351 T1 SI 0625351T1 SI 9430223 T SI9430223 T SI 9430223T SI 9430223 T SI9430223 T SI 9430223T SI 0625351 T1 SI0625351 T1 SI 0625351T1
Authority
SI
Slovenia
Prior art keywords
etofibrate
retinopathy
treatment
pharmaceutical compositions
compositions containing
Prior art date
Application number
SI9430223T
Other languages
Slovenian (sl)
Inventor
Hans Dr. Med. Erbler
Original Assignee
Merz + Co. Gmbh & Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz + Co. Gmbh & Co. filed Critical Merz + Co. Gmbh & Co.
Publication of SI0625351T1 publication Critical patent/SI0625351T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the use of etofibrate for the treatment of diabetic angiopathy and retinopathy and to pharmaceutical compositions which contain etofibrate in the form of pellets and which are particularly suitable for the abovementioned indication.
SI9430223T 1993-05-19 1994-05-02 Use of Etofibrate and pharmaceutical compositions containing etofibrate in the treatment of diabetic angio- and retinopathy SI0625351T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4317127A DE4317127A1 (en) 1993-05-19 1993-05-19 Use of etofibrate and pharmaceutical compositions containing etofibrate for the treatment of diabetic angio-and retinopathy
EP94106819A EP0625351B1 (en) 1993-05-19 1994-05-02 Use of Etofibrate and pharmaceutical compositions containing etofibrate in the treatment of diabetic angio- and retinopathy

Publications (1)

Publication Number Publication Date
SI0625351T1 true SI0625351T1 (en) 1999-04-30

Family

ID=6488713

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9430223T SI0625351T1 (en) 1993-05-19 1994-05-02 Use of Etofibrate and pharmaceutical compositions containing etofibrate in the treatment of diabetic angio- and retinopathy

Country Status (7)

Country Link
EP (1) EP0625351B1 (en)
AT (1) ATE175349T1 (en)
DE (2) DE4317127A1 (en)
DK (1) DK0625351T3 (en)
ES (1) ES2126015T3 (en)
GR (1) GR3029898T3 (en)
SI (1) SI0625351T1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2531097C (en) * 2003-07-02 2012-10-09 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1941217C3 (en) * 1969-08-13 1974-06-12 Merz & Co, 6000 Frankfurt Alpha square brackets on 2- (p-chlorophenoxy) -isobutyryril square brackets on-beta-nicotinoylglycol ester and process for its preparation
IT1180507B (en) * 1984-06-29 1987-09-23 Roberto Valducci PROCEDURE FOR THE PREPARATION OF ETOFIBRATE OR SUBSTANCES OF EQUAL OR SIMILAR CHARACTERISTICS, IN MICROGUNULI-DELAY AND PRODUCT OBTAINED WITH SUCH PROCEDURE
DE3621861A1 (en) * 1986-06-30 1988-01-14 Laszlo Dr Med Ilg USE OF ARYLOXYCARBONIC ACID DERIVATIVES AGAINST DERMATOLOGICAL DISEASES
DE4021678C2 (en) * 1990-07-07 1994-07-07 Merz & Co Gmbh & Co Process for the preparation of small-sized shaped articles with a high etofibrate content and controlled release of active ingredient, their use and existing orally administrable administration forms

Also Published As

Publication number Publication date
ATE175349T1 (en) 1999-01-15
EP0625351A1 (en) 1994-11-23
EP0625351B1 (en) 1999-01-07
DE59407576D1 (en) 1999-02-18
DE4317127A1 (en) 1994-11-24
ES2126015T3 (en) 1999-03-16
GR3029898T3 (en) 1999-07-30
DK0625351T3 (en) 1999-08-30

Similar Documents

Publication Publication Date Title
GR3006177T3 (en)
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
DE69531098D1 (en) PIPERIDINE AND PYRROLIDINE
IL99515A0 (en) Calcium uptake inhibitors
MX9805705A (en) Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses.
IL98917A0 (en) Piperidyl ethers and thioethers and their use as inhibitors of cholesterol biosynthesis
EP0133766A3 (en) Coumarin derivatives, pharmaceutical compositions containing the same, and the use thereof in the treatment of cancer
ES8707488A1 (en) Biologically active ketone derivative, preparation and use.
UA42722C2 (en) Sulphides, sulphoxides and sulphones or the pharmaceutically acceptable salts thereof and pharmaceutical composition containing them
ITRM910730A1 (en) PHARMACEUTICAL COMPOSITIONS, FOR TOPICAL USE, CONTAINING "SCAVENGERS" OF FREE OXYGEN RADICALS AND ANTIBACTERIALS, INDICATED IN THE THERAPY OF SURFACE TISSUES.
DE68905973T2 (en) SYNERGISTIC FOOD COMPOSITIONS CONTAINING CHLORODEOXYSUCRASE, AND COMPOSITIONS THEREOF.
GR3029898T3 (en) Use of Etofibrate and pharmaceutical compositions containing etofibrate in the treatment of diabetic angio- and retinopathy.
DE3068880D1 (en) Carbamates, their preparation and pharmaceutical compositions containing them
IL99511A0 (en) Calcium uptake inhibitors
IL99512A0 (en) Calcium uptake inhibitors
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
ES8706441A1 (en) Prepn. of sulphirdine-progestagen compsns.
ATE82855T1 (en) 2',3'-DIDEOXYPURINUCLEOSIDE/PURINUCLEOSIDPHOSPHORYLASE COMBINATION THERAPY INHIBITOR AND COMPOSITIONS THEREOF.

Legal Events

Date Code Title Description
KO00 Lapse of patent

Effective date: 20070125